Figure 1
Site of binding of different antibodies used in the IHC detection of HER-2 overexpression in breast cancer. The exact epitope recognised by some reagents is presently unknown.
Figure 1 | British Journal of Cancer
Site of binding of different antibodies used in the IHC detection of HER-2 overexpression in breast cancer. The exact epitope recognised by some reagents is presently unknown.
